KIAA1429通过TGF-Β1/Smad路径促进形形成
Shuai Ren1, Yingchang Ji1, Mengmeng Wang1
1The Plastic and Aesthetic Surgery Center, The First Affiliated Hospital of Shantou University Medical College, Shantou, China.
Current molecular medicine
|November 8, 2024
概括
一种m6A甲基转移酶KIAA1429通过调节TGF-β1/Smad信号传递来促进 keloid 的形成. 它在 keloids 中的降低调节表明,对于过度的原蛋白生产来说,它是一个治疗目标.
科学领域:
- 皮肤病学 皮肤病学
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 化形成涉及过度的细胞外基质生产和失调的原反应.
- 修改N6-甲基-腺素 (m6A) 在 keloid 病原发生过程中至关重要.
研究的目的:
- 调查m6A甲基转移酶KIAA1429在 keloid 形成中的作用和机制.
主要方法:
- 定量实时PCR (qRT-PCR) 是一种方法.
- 西方斑点分析分析
- 免疫光效应 免疫光效应
- 过井迁移的测定方法
- m6A特异性RNA免疫沉,然后进行qPCR (MeRIP-qPCR).
主要成果:
- 在 keloid 组织中,KIAA1429 表达减少.
- 过度表达KIAA1429抑制了纤维细胞迁移,降低了原蛋白 (COL1A1) 和α-平滑肌肉活性蛋白 (α-SMA) 的水平.
- KIAA1429调节了TGF-β1 m6A的修饰,影响了TGF-β1 mRNA的稳定性和TGF-β1/Smad通路,从而影响了 keloid 发育.
结论:
- KIAA1429在通过TGF-β1/Smad通路促进胆固醇形成方面发挥着重要作用.
- 向KIAA1429提供了潜在的治疗策略,用于 keloid 治疗.
相关概念视频
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
MAPK Signaling Cascades
5.2K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.2K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K


